採用情報
By joining Lonza, you will get to work with some of the world’s top experts in the space, while developing advanced therapies with a potentially life-saving outcome.
Behnam Ahmadian Baghbaderani
Global Head of Process Development
早期の利点IND申請を信頼できるパートナーと
細胞・遺伝子治療薬の創薬から上市まで、最も経験豊富な一社であるLonzaと協業し、INDへの道を加速し、CMC工程を確実なものにし、臨床での成功の可能性を高めませんか。
多様な性質の分子 – 専門的デザイン
細胞・遺伝子治療薬のモダリティは、広範囲に及びます。この分野のCDMO（医薬品受託製造開発機関）のリーディングカンパニーとして、当社はお客様の治療薬に必要な専門知識を提供するために、常に投資を行い、新たなモダリティ等、幅広い領域に及び経験を構築するよう努めています。
当社は、お客様の開発（治験段階と商用生産段階）に適した幅広いサービスを提供します。臨床や商用生産、治療薬の構想から患者さんへの投与に至るまで、さまざまな目標を達成するお手伝いをします。
cGMPに準拠した製造用にカスタマイズした細胞と遺伝子のテクノロジー
お客様に対しテクノロジーのみにとらわれないようにする一方で、当社専有の細胞・遺伝子治療薬の製造技術は、開発のどのステージでも常にご利用になれます。
Overview
Our experienced team of scientists and engineers work closely with you to ensure seamless project execution and regulatory compliance. We are committed to delivering high-quality products and services that meet your exacting specifications and timelines.
Choose Lonza as your CDMO partner for your cell and gene therapy development and manufacturing needs. Contact us today to learn more about our services and how we can help bring your therapy to market faster.
Our state-of-the-art facilities and high quality control processes also ensure that your product is manufactured to the highest standards.
Our approach to develop and manufacture your therapy from concept to commercialization and beyond
Our New Product Introduction (NPI) and Lifecycle program, maps out your entire journey to commercialization. It accounts for each key milestone with checkpoints, to ensure you meet all required quality standards as your therapy progresses towards commercialization. The NPI program leverages our heritage and longstanding experience in establishing cGMP manufacturing standards. It combines both corporate and local quality standards customized for cell and gene therapies, to de-risk your journey to commercialization.
After working with several CDMOs, Lonza is head and shoulders above the rest. Client success relies heavily on CDMO competency, trustworthiness, transparency, follow-up and follow-though. Lonza MFG, MSAT, QA, QC and Supply Chain worked tirelessly together to deliver our GMP product and deliver it on time. They were a great partner and seemed to lose just as much sleep as we did navigating the processing and testing challenges that come with taking a clinical program to the next phase."
- A CGT Customer
グローバルネットワーク
細胞・遺伝子治療薬の医薬品製造拠点
細胞・遺伝子
関連するコンテンツ
